Structured evidence table for Taurine Metabolic Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Taurine Metabolic Health Randomized Trial | Recent experimental evidence suggests that taurine (2-aminoethanesulfonic acid) deficiency contributes to these conditions, despite taurine being classified as a conditionally essential amino acid. | 2 | Chu MHM (2026) | Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial. |
| Taurine Metabolic Health Randomized Trial | Purpose This study aims to assess whether a 6-month oral taurine supplementation program improves blood glucose control and other health parameters among healthcare workers. | 2 | Chu MHM (2026) | Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial. |
| Taurine Metabolic Health Randomized Trial | Cirrhosis is a major and growing global cause of morbidity and premature mortality, driven largely by alcohol-associated liver disease and metabolic dysfunction–associated steatotic liver disease alongside chronic viral hepatitis. | 2 | Sasidharan Swarup (2026) | A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis |
| Taurine Metabolic Health Randomized Trial | Fatigue in chronic liver disease is a multidimensional syndrome involving reduced physical and mental energy, impaired motivation, reduced endurance, and slowed cognition that is often poorly relieved by rest. | 2 | Sasidharan Swarup (2026) | A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis |
| Taurine Metabolic Health Randomized Trial | , , Despite its impact, there is no universally effective, guideline-endorsed pharmacologic therapy for fatigue in cirrhosis. | 2 | Sasidharan Swarup (2026) | A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis |
| Taurine Metabolic Health Randomized Trial | As the cirrhosis population ages and lives longer with decompensation, the clinical focus can no longer remain limited to “hard” outcomes (bleeding, ascites, and encephalopathy) alone; patient-reported outcomes and day-to-day functioning matter because they determine disability, health care use, and whether patients can participate meaningfully in care pathways. | 2 | Sasidharan Swarup (2026) | A randomized controlled trial of L -taurine for fatigue in decompensated cirrhosis |
Source documents